Cardinal Health (CAH)
Healthcare · NYSE · US
Price as at 2 Oct 2026, 03:05 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Cardinal Health trades at $230.09, which is 59% above the $94.32 our fair value estimate puts on the business. On that measure it screens as expensive, which is not the same as saying it will fall.
Our moat model scores it 25 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
It changes hands at 35.9 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.
CAH dividend history
Dividends per share by year
| Year | Total per share | Payments |
|---|---|---|
| 2026 (year to date) | $2.05 | 4 |
| 2025 | $2.03 | 4 |
| 2024 | $1.51 | 3 |
| 2023 | $2.00 | 4 |
| 2022 | $1.98 | 4 |
| 2021 | $1.96 | 4 |
| 2020 | $1.94 | 4 |
| 2019 | $1.92 | 4 |
| 2018 | $1.89 | 4 |
| 2017 | $1.83 | 4 |
| 2016 | $1.73 | 4 |
Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.
CAH earnings and analyst estimates
Recommendation mix, 17 published ratings
Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.
About Cardinal Health
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
CAH passes 1 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Super investor ownership
16 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- Cliff Asness, AQR CAPITAL MANAGEMENT LLC$411.65M · 0.1% of book
- D. E. Shaw, D. E. Shaw & Co., Inc.$130.72M · 0.1% of book
- Renaissance Technologies, RENAISSANCE TECHNOLOGIES LLC$130.68M · 0.2% of book
- Arrowstreet Capital, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP$123.08M · 0.1% of book
- Israel Englander, MILLENNIUM MANAGEMENT LLC$60.51M · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
Politician trades in CAH
We hold 10 disclosed trades in CAH by members of Congress and executive-branch officials. The latest 5:
- Donald J Trump · Executive branchBuy · $15,001 - $50,000 · traded 12 Jun 2026 · disclosed 22 Aug 2026
- Donald J Trump · Executive branchSell · $15,001 - $50,000 · traded 11 May 2026 · disclosed 1 Jul 2026
- Donald J Trump · Executive branchBuy · $15,001 - $50,000 · traded 5 May 2026 · disclosed 1 Jul 2026
- Donald J Trump · Executive branchSell · $50,001 - $100,000 · traded 27 Apr 2026 · disclosed 1 Jul 2026
- Alan Armstrong · SenateBuy · $1,001 - $15,000 · traded 27 Mar 2026 · disclosed 21 Jul 2026
A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.
CAH peers
The largest companies in the same industry, then in the same sector.
- NOVO-B.CO Novo Nordisk
- LLY Eli Lilly and Company
- JNJ Johnson & Johnson
- ABBV AbbVie Inc.
- MRK Merck & Co., Inc.
- UNH UnitedHealth Group Incorporated
- NVSEF Novartis AG
- AZN AstraZeneca (ADR)
Every healthcare company we cover is on the Healthcare hub.
Common questions
Is Cardinal Health (CAH) undervalued?
Against our fair value estimate of $94.32, CAH at $230.09 is 59% above fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
Which funds own CAH?
16 of the institutions we track reported a position in CAH in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
What is CAH's P/E ratio?
CAH trades at 35.9 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.
Does Cardinal Health (CAH) pay a dividend?
Yes. Cardinal Health yields 0.87% at the current share price. It has paid $2.05 per share over the trailing twelve months. It has paid a dividend in each of the last 40 complete calendar years. A dividend is declared by the board and can be cut at any time; a yield is a fact about the current price, not a promise.
Where does SteadyShares get its CAH data?
Fundamentals for CAH come from company filings and exchange data, as listed on NYSE; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 2 Oct 2026, 03:05 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for CAH, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.